Clinical Trial

Performance and Safety of Semical Dermal Fillers in Facial Rejuvenation

Study acronym: SEMDERMA
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 8, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of the study is to verify safety and performance of Semical dermal fillers according to real-world data.
Trial Details
NCT Number NCT07160777
Lead Sponsor Semikal Technology
Conditions Facial Aging, Skin Rejuvenation, Volume Defects in the Mid-face, Lip Augmentation and Correction of Perioral Rhytids, Marionette Lines, Nasolabial Fold Correction, Periorbital Wrinkles, Facial Wrinkles and Rhytides Reduction
Enrollment 80 participants
Start Date 2024-11-01
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-08